Chapter 14

Potential Targets for the Treatment of Depressive Disorders

Hans M. Rollema

Hans M. Rollema

Pfizer Global Research and Development, Groton Laboratories, MS 8220-4159, Department of Neuroscience, Eastern Point Road, Groton, CT06340, USA

Search for more papers by this author
Jeffrey Sprouse

Jeffrey Sprouse

Pfizer Global Research and Development, Groton Laboratories, MS 8220-4159, Department of Neuroscience, Eastern Point Road, Groton, CT06340, USA

Search for more papers by this author
First published: 21 January 2005

Summary

This chapter contains sections titled:

  • Introduction

  • Improving Serotonergic Antidepressants

  • Incorporating Serotonin Autoreceptor Antagonism

  • Novel Non-Serotonergic Antidepressant Targets

  • Novel Intracellular Targets

  • Summary and Conclusions

  • References

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.